Cite
Rimar D, Awisat A, Kaly L, et al. Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review' by Akiyama . Ann Rheum Dis. 2020;doi: 10.1136/annrheumdis-2020-218790.
Rimar, D., Awisat, A., Kaly, L., Slobodin, G., Rosner, I., Rozenbaum, M., Ginsberg, S., Starosvetsky, E., Alpert, A., & Shen-Orr, S. (2020). Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review' by Akiyama . Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2020-218790
Rimar, Doron, et al. "Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review' by Akiyama ." Annals of the rheumatic diseases vol. (2020). doi: https://doi.org/10.1136/annrheumdis-2020-218790
Rimar D, Awisat A, Kaly L, Slobodin G, Rosner I, Rozenbaum M, Ginsberg S, Starosvetsky E, Alpert A, Shen-Orr S. Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review' by Akiyama . Ann Rheum Dis. 2020 Sep 09; doi: 10.1136/annrheumdis-2020-218790. Epub 2020 Sep 09. PMID: 32907803.
Copy
Download .nbib